Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12121540
CBL inhibitors and compositions for use in adoptive cell therapy
granted patentUS 12116346
Human plasma kallikrein inhibitors
granted patentUS 12116343
Inhibitors of APOL1 and methods of using same
granted patentUS 12115156
Compositions of CXCR4 inhibitors and methods of preparation and use
granted patentUS 12103907
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
granted patentUS 12097213
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation thera
granted patentUS 12097210
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted patentUS 12097262
mTORC1 inhibitors
granted patentUS 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted patentUS 12083098
Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form Ξ² inhibito
granted patentUS 12084438
GCN2 inhibitors and uses thereof
granted patentUS 12084447
SHP2 phosphatase inhibitors and methods of use thereof
granted patentUS 12083137
Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors
granted patentUS 12083113
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted patentUS 12076324
Cancer treatments using combinations of CDK and ERK inhibitors
granted patentUS 12077515
Selective histone deacetylase inhibitors for the treatment of human disease
granted patentUS 12077605
Cysteine protease inhibitors and methods of use thereof
granted patentUS 12077506
Indane derivatives as hypoxia inducible factor-2(Ξ±) inhibitors
granted patentUS 12071411
Inhibitors of HIF-2Ξ± and methods of use thereof
granted patentUS 12070460
Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors
granted patentUS 12071428
Indazole compounds as kinase inhibitors
granted patentUS 12065448
Heteroaryl plasma kallikrein inhibitors
granted patentUS 12060396
Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis
granted patentUS 12060362
Inhibitors of glucose transporters (GLUTs)
granted